OMF Science Wednesday – Personalized Medicine

In honor of last week’s conference at Stanford University on Personalized Medicine, at #OMFScienceWednesday we ask the question: What is personalized health?
Whether you call it personalized medicine, precision health, or P4 medicine, we are talking about a current revolution in the way health and disease are being studied, and the way healthcare is being practiced. This means we are moving away from the one-size-fits-all approach, and towards more tailored therapies that account for individual variations at the clinical and molecular level. This means we are aiming to predict the risk and eventually prevent the onset of disease. This means a data-driven revolution, that uses the cutting-edge molecular technologies we talked about last week and sophisticated big data analysis, to predict the best ways to treat disease and maintain health in each person. This means empowering patients to take a more active role in their own healthcare. This means focusing on turning from reactive (treating disease) to proactive (maintaining wellness).

A personalized health approach to research is especially exciting in ME/CFS because of how complex and variable this disease is across patients. This is why OMF funded the big data study on severely ill patients (https://www.omf.ngo/mecfs-severely-ill-big-data-study/). We already know that different patients respond to different treatments, and personalized health research will help us not only to understand why that is, but to find even better treatments or combinations thereof. This is already starting to happen in cancer, where genome sequence information is used to select the most effective drugs for individual patients.
Much of the research OMF supports takes place at Stanford Medicine. Read more about Stanford Medicine’s commitment to precision health in research, in Dean Lloyd Minor’s Forbes op-ed: http://med.stanford.edu/…/dean-minor-on-precision-health.ht…
Dean Minor kicked off the Personalized Health conference at Stanford University, and Ron Davis spoke there about ME/CFS research on Friday afternoon. See the entire program here: https://app.certain.com/profile/web/index.cfm… and follow the live Twitter feed here: http://twitter.com/hashtag/PH17
Facebook
Twitter
WhatsApp
Email

Latest News

Text across top of image reads: "Experts in infection associated chronic illness" with "WE WANT YOU!" bolded below it. Hand with finger pointed out at viewer. "Apply now" buttons to the left and right with mouse cursor clicking on them.

Infection-associated chronic disease experts needed at ARPA-H

Congress launched ARPA-H (the Advanced Research Projects Agency for Health) this past March to focus on high-risk, high-reward research projects with the goal to solve intractable health problems. As ARPA-H is in the process of hiring its first cohort of program managers, #MEAction and a coalition of chronic disease advocacy groups have published an open

Read More »

BOLD ACTION is a Commitment to Healthcare Justice for People with ME

BOLD ACTION to me, means mobilizing our community to publicly demonstrate our deep and intense—as opposed to shallow and passive—commitment to seeing healthcare justice for people with ME. It is about bringing our issues to the forefront of public consciousness and putting strong pressure on our leaders to act. Taking BOLD ACTION is both a

Read More »

Help keep our work going

We rely on donations from people like you to keep fighting for equality for people with ME.

Donate

Get actions alerts and news direct to your inbox

You can choose what you want to be kept up to date on.

Subscribe
Scroll to Top